Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
The company hosted Symbiosis 2026 at its 2-acre manufacturing facility in Bengaluru, inaugurated in 2024
International Day of Yoga 2026 event highlights preventive healthcare, wellness-focused lifestyles and the growing global acceptance of yoga
The event is expected to bring together health and wellness enthusiasts for an afternoon of insights, learning and practical takeaways
The new facility will produce precision extruded medical tubing used in minimally invasive medical devices
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
New facility equipped with advanced imaging technology to support 200 additional procedures a month and benefit nearly 3,000 more patients annually
Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
Subscribe To Our Newsletter & Stay Updated